Dave Taggart, a seasoned management consultant has dedicated his career to innovation in health and life sciences. With deep expertise in R&D, commercial strategy, and business development, Dave plays a pivotal role in Glycyx as CBO. His strategic thinking and global industry insights are invaluable as Glycyx prepares for Series A funding and strategic collaborations and partnerships. His pivotal role in defining the strategic direction of Humira across multiple possible indications shaped our strategy for axelopran.